- Lobbying
- Jessica AND Layson
Lobbying Arrangements Results for 'Jessica Layson'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Policy measures affecting home health and hospice care |
Visiting Nurse Associations of America
|
VENN STRATEGIES, LLC | |||
Details General health issues relating to patient transitions of care |
National Transitions of Care Coalition
|
VENN STRATEGIES, LLC | |||
Details Laws and policies affecting health care and group purchasing organizations |
AMERINET, INC
|
VENN STRATEGIES, LLC | |||
Details Orphan drugs and rare diseases, matters related to drug reimbursement policy. Orphan drugs and rare disease matters |
BioMarin Pharmaceutical, Inc.
|
VENN STRATEGIES | |||
Details General issues related to policy to prevent and treat U.S. obesity. General Issues related to policy to prevent and treat U.S. obesity. |
Campaign to End Obesity Action Fund
|
VENN STRATEGIES | |||
Details Legislation and other proposed policy change impacting S Corporation ESOPs. |
EMPLOYEE-OWNED S CORPORATIONS OF AMERICA
|
VENN STRATEGIES | |||
Details General policy issues relating to academic medicine. |
UNIVERSITY OF WISCONSIN MEDICAL FOUNDATION/UW HEALTH
|
VENN STRATEGIES | |||
Details Trade and investment policy related to the United States rail manufacturing industry. Policy related to the United States rail manufacturing industry. Policy related to the security and cybersecuri... |
Rail Security Alliance
|
VENN STRATEGIES | |||
Details General Healthcare Issues pertaining to Eli Lilly and Company, including but not limited to drug pricing, importation, and innovation policies. Proposals on patent policy impacting biopharmaceutica... |
Eli Lilly and Company
|
VENN STRATEGIES | |||
Details Medicare reimbursement and incident-to billing, Medicare hospice restrictions, telehealth, transparency, healthcare competition, coverage and access to mental health and primary care services, wind... |
AMERICAN ACADEMY OF PHYSICIAN ASSOCIATES
|
in-house lobbying |